# Ketorolac Premedication for Anesthetic Efficiency of IANB & Postendodontic Pain in Teeth With Irreversible Pulpitis

> **NCT02940405** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 38 (estimated)

## Conditions studied

- Irreversible Pulpitis

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02940405
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2017-10
- **Final completion:** 2018-01
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02940405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02940405, "Ketorolac Premedication for Anesthetic Efficiency of IANB & Postendodontic Pain in Teeth With Irreversible Pulpitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02940405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*